Koers Sigilon Therapeutics, Inc.
Aandelen
SGTX
US82657L2060
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 60 | 14-08-18 | |
Director of Finance/CFO | 58 | 01-11-19 | |
Philip Johnson
PSD | President | 59 | 11-08-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 60 | 14-08-18 | |
Philip Johnson
PSD | President | 59 | 11-08-23 |
Gordon Brooks
BRD | Director/Board Member | - | 11-08-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-0,02% | 42,11 mld. | |
+44,93% | 40,08 mld. | |
+5,04% | 40 mld. | |
-11,32% | 26,87 mld. | |
+5,25% | 24,58 mld. | |
-23,83% | 18,44 mld. | |
-1,62% | 11,94 mld. | |
+22,75% | 11,66 mld. | |
+6,44% | 11,01 mld. |